Literature DB >> 12202558

Sensitivity of three urinary antigen tests associated with clinical severity in a large outbreak of Legionnaires' disease in The Netherlands.

Ed P F Yzerman1, Jeroen W den Boer, Kamilla D Lettinga, Joop Schellekens, Jacob Dankert, Marcel Peeters.   

Abstract

In 1999 an outbreak involving 188 patients with Legionnaires' disease (LD) occurred among visitors to a flower show in the Netherlands. Two enzyme immunoassays (Binax and Biotest) and one immunochromatographic assay (Binax NOW) were tested, using urine samples from LD patients from the 1999 outbreak. Sensitivity was calculated using positive culture and/or seroconversion as the "gold standard" in outbreak-related patients with radiographically confirmed pneumonia who fulfilled the epidemiological critera. The Binax EIA, Biotest EIA, and Binax NOW assay showed overall sensitivities of 69, 71, and 72%, respectively. When the tests were performed with concentrated urine samples, the overall sensitivities increased to 79, 74, and 81%, respectively. Using multiple logistic regression analysis with backward elimination, a statistically significant association was found between clinical severity and test sensitivity for all tests. For patients with mild LD, the test sensitivities ranged from 40 to 53%, whereas for patients with severe LD who needed immediate special medical care, the sensitivities reached 88 to 100%. These findings have major implications for the diagnostic process in patients with mild pneumonia and suggest that patients with mild pneumonia may go underdiagnosed if urine antigen tests alone are used.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12202558      PMCID: PMC130686          DOI: 10.1128/JCM.40.9.3232-3236.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Rapid diagnosis of Legionnaires' disease using an immunochromatographic assay for Legionella pneumophila serogroup 1 antigen in urine during an outbreak in the Netherlands.

Authors:  P C Wever; E P Yzerman; E J Kuijper; P Speelman; J Dankert
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

2.  Detection of Legionella pneumophila antigen in urine samples by the BinaxNOW immunochromatographic assay and comparison with both Binax Legionella Urinary Enzyme Immunoassay (EIA) and Biotest Legionella Urin Antigen EIA.

Authors:  Jürgen H Helbig; Søren A Uldum; P Christian Lück; Timothy G Harrison
Journal:  J Med Microbiol       Date:  2001-06       Impact factor: 2.472

Review 3.  Advances in the epidemiology and control of Legionella infections.

Authors:  C W Hoge; R F Breiman
Journal:  Epidemiol Rev       Date:  1991       Impact factor: 6.222

4.  Detection of Legionella pneumophila serogroup 1 antigen in nonconcentrated urine and urine concentrated by selective ultrafiltration.

Authors:  J A Domínguez; J M Manterola; R Blavia; N Sopena; F J Belda; E Padilla; M Giménez; M Sabrià; J Morera; V Ausina
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

5.  Subclinical Legionella infection in workers near the source of a large outbreak of Legionnaires disease.

Authors:  H C Boshuizen; S E Neppelenbroek; H van Vliet; J F Schellekens; J W den Boer; M F Peeters; M A Conyn-van Spaendonck
Journal:  J Infect Dis       Date:  2001-07-16       Impact factor: 5.226

6.  Reevaluation of the definition of Legionnaires' disease: use of the urinary antigen assay. Community Based Pneumonia Incidence Study Group.

Authors:  J F Plouffe; T M File; R F Breiman; B A Hackman; S J Salstrom; B J Marston; B S Fields
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

7.  Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association.

Authors:  M S Niederman; J B Bass; G D Campbell; A M Fein; R F Grossman; L A Mandell; T J Marrie; G A Sarosi; A Torres; V L Yu
Journal:  Am Rev Respir Dis       Date:  1993-11

8.  Evaluation of a rapid immunochromatographic assay for the detection of Legionella antigen in urine samples.

Authors:  J Domínguez; N Galí; L Matas; P Pedroso; A Hernández; E Padilla; V Ausina
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-12       Impact factor: 3.267

9.  Comparison of the Binax Legionella urinary antigen enzyme immunoassay (EIA) with the Biotest Legionella Urin antigen EIA for detection of Legionella antigen in both concentrated and nonconcentrated urine samples.

Authors:  J A Domínguez; N Galí; P Pedroso; A Fargas; E Padilla; J M Manterola; L Matas
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

Review 10.  Legionnaires' disease: clinical, epidemiological, and public health perspectives.

Authors:  R F Breiman; J C Butler
Journal:  Semin Respir Infect       Date:  1998-06
View more
  27 in total

1.  Comparison of diagnostic sensitivities of three assays (Bartels enzyme immunoassay [EIA], Biotest EIA, and Binax NOW immunochromatographic test) for detection of Legionella pneumophila serogroup 1 antigen in urine.

Authors:  Carmen Guerrero; Carmen M Toldos; Genoveva Yagüe; Cristobal Ramírez; Tomás Rodríguez; Manuel Segovia
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

2.  Value of serological testing for diagnosis of legionellosis in outbreak patients.

Authors:  Almudena Rojas; M Dolores Navarro; Francisca E Fornés; Estefanía Serra; Encarnación Simarro; José Rojas; Joaquín Ruiz
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

3.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

Review 4.  Optimal sampling sites and methods for detection of pathogens possibly causing community-acquired lower respiratory tract infections.

Authors:  K Loens; L Van Heirstraeten; S Malhotra-Kumar; H Goossens; M Ieven
Journal:  J Clin Microbiol       Date:  2008-11-19       Impact factor: 5.948

Review 5.  Current and emerging Legionella diagnostics for laboratory and outbreak investigations.

Authors:  Jeffrey W Mercante; Jonas M Winchell
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

Review 6.  Diagnosis of Legionella infection in Legionnaires' disease.

Authors:  J W Den Boer; E P F Yzerman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-12       Impact factor: 3.267

7.  Sensitivity of urinary antigen test in relation to clinical severity in a large outbreak of Legionella pneumonia in Spain.

Authors:  R M Blázquez; F J Espinosa; C M Martínez-Toldos; L Alemany; M C García-Orenes; M Segovia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-07       Impact factor: 3.267

8.  Legionella pneumophila DNA in serum samples during Legionnaires' disease in relation to C-reactive protein levels.

Authors:  F L van de Veerdonk; C P C de Jager; J J A Schellekens; C J J Huijsmans; F Beaumont; M H A Hermans; P C Wever
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-10-15       Impact factor: 3.267

Review 9.  Improving outcomes of elderly patients with community-acquired pneumonia.

Authors:  Félix Gutiérrez; Mar Masiá
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

10.  Utility of real-time PCR for diagnosis of Legionnaires' disease in routine clinical practice.

Authors:  Bram M W Diederen; Jan A J W Kluytmans; Christina M Vandenbroucke-Grauls; Marcel F Peeters
Journal:  J Clin Microbiol       Date:  2007-12-19       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.